Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study.

Iliodromiti S, Lan VT, Tuong HM, Tuan PH, Humaidan P, Nelson SM.

J Ovarian Res. 2013 Dec 26;6(1):93. doi: 10.1186/1757-2215-6-93.

2.

Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.

Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM.

Hum Reprod. 2013 Sep;28(9):2529-36. doi: 10.1093/humrep/det304. Epub 2013 Jul 19.

3.

Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.

Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L.

Fertil Steril. 2012 Jun;97(6):1316-20. doi: 10.1016/j.fertnstert.2012.03.015. Epub 2012 Apr 3.

PMID:
22480822
4.

Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support.

Imbar T, Kol S, Lossos F, Bdolah Y, Hurwitz A, Haimov-Kochman R.

Hum Reprod. 2012 Mar;27(3):753-9. doi: 10.1093/humrep/der463. Epub 2012 Jan 16.

5.

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

Humaidan P, Kol S, Papanikolaou EG; Copenhagen GnRH Agonist Triggering Workshop Group.

Hum Reprod Update. 2011 Jul-Aug;17(4):510-24. doi: 10.1093/humupd/dmr008. Epub 2011 Mar 30. Review.

6.

'Luteal coasting' after GnRH agonist trigger - individualized, HCG-based, progesterone-free luteal support in 'high responders': a case series.

Kol S, Breyzman T, Segal L, Humaidan P.

Reprod Biomed Online. 2015 Dec;31(6):747-51. doi: 10.1016/j.rbmo.2015.09.001. Epub 2015 Sep 9.

PMID:
26507279
7.

WITHDRAWN: Luteal phase support in assisted reproduction cycles.

Daya S, Gunby JL.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD004830. doi: 10.1002/14651858.CD004830.pub2. Review.

PMID:
18646113
8.

Luteal phase support in assisted reproduction cycles.

Daya S, Gunby J.

Cochrane Database Syst Rev. 2004;(3):CD004830. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD004830.

PMID:
15266541
9.
11.

Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.

Bar-Hava I, Mizrachi Y, Karfunkel-Doron D, Omer Y, Sheena L, Carmon N, Ben-David G.

Fertil Steril. 2016 Aug;106(2):330-3. doi: 10.1016/j.fertnstert.2016.04.004. Epub 2016 Apr 22.

PMID:
27114332
12.

Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?

Gurbuz AS, Deveer R, Kucuk M, Ozcimen N, Incesu D, Koseoglu S.

J Clin Med Res. 2016 May;8(5):396-401. doi: 10.14740/jocmr2500w. Epub 2016 Mar 20.

13.

Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches.

Humaidan P, Engmann L, Benadiva C.

Fertil Steril. 2015 Apr;103(4):879-85. doi: 10.1016/j.fertnstert.2015.01.034. Epub 2015 Feb 11. Review.

PMID:
25681859
14.

Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.

Krause BT, Ohlinger R.

Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):87-92. Epub 2005 Dec 22.

PMID:
16377065
15.

GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study.

Kol S, Humaidan P, Itskovitz-Eldor J.

Hum Reprod. 2011 Oct;26(10):2874-7. doi: 10.1093/humrep/der220. Epub 2011 Jul 21.

17.

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.

Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, van Wely M.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD008046. doi: 10.1002/14651858.CD008046.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD008046.

PMID:
21069701
18.

GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis.

Engmann L, Benadiva C, Humaidan P.

Reprod Biomed Online. 2016 Mar;32(3):274-85. doi: 10.1016/j.rbmo.2015.12.007. Epub 2016 Jan 6. Review.

PMID:
26803205
19.

Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.

Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T, Eldar-Geva T.

Hum Reprod. 2006 May;21(5):1260-5. Epub 2006 Jan 26.

Items per page

Supplemental Content

Write to the Help Desk